The present work describes a validated reverse phase high performance liquid chromatographic method for simultaneous estimation of telmisartan and hydrochlorothiazide in tablet formulation. Chromatography was performed on a ODS Hypersil C18 (25 cm×4.6 mm I.D) column from thermo in isocratic mode with mobile phase containing acetonitrile:0.05 M KH 2 PO 4 pH 3.0 (60:40). The flow rate was 1.0 ml/min and the eluent was monitored at 271 nm. The selected chromatographic conditions were found to effectively separate telmisartan (RT-5.19 min) and hydrochlorothiazide (RT-2.97 min). Linearity for telmisartan and hydrochlorothiazide were found in the range of 4.1-20.48 µg/ml and 1.28-6.4 µg/ml, respectively. The proposed method was found to be accurate, precise, reproducible and specific and can be used for simultaneous analysis of these drugs in tablet formulation.
*For correspondence
Telmisartan is 4 www.ijpsonline.com
Telmisartan is a new angiotensin II receptor antagonist for the treatment of essential hypertension usually given in combination with hydrochlorothiazide. The combination is useful in the treatment of mild to moderate hypertension, well tolerated with a lower incidence of cough than ACE inhibitors. The marketed tablet formulation contains telmisartan and hydrochlorothiazide in the ratio of 40:12.5 mg. Literature survey revealed linear sweep polarography 1 , parallel catalytic hydrogen wave method 2 , and HPLC 3 method for estimation of telmisartan alone in pharmaceutical preparations.
formulations. Twenty tablets were weighed and powdered. Accurately weighed quantity of tablet powder equivalent to about 25 mg of telmisartan was transferred to 50.0 ml volumetric flask, added 25 ml of methanol and shaken for ten minutes, the volume was then adjusted to mark with methanol and mixed. The solution was filtered through whatman filter paper no. 41 and the filtrate was then appropriately diluted with mobile phase to get a final concentration of 8 µg/ml of telmisartan and 2.5 µg/ml of hydrochlorothiazide. Twenty micro liters of sample preparation was injected into injector of liquid Hydrochlorothiazide in combination with other drugs is chromatograph and chromatography was performed on reported to be estimated by spectrophotometric 4, 5 , ODS Hypersil C-18 RP column (25 cm×4.6 mm I.D) using HPLC 6,7 methods. The analytical method for simultaneous a mixture of acetonitrile:0.05 M KH determination of telmisartan and hydrochlorothiazide in mobile phase. The eluent was monitored at 271 nm. A pharmaceutical formulation has not been reported so far.
typical chromatogram The present work describes a validated reverse phase hydrochlorothiazide is shown in fig. 1 . Each sample was HPLC method for simultaneous determination of these injected and analysed in triplicate. From the mean peak drugs in tablets.
area of telmisartan and hydrochlorothiazide the amount of drug in tablet was computed (Table 1 ). An isocratic HPLC system (Shimadzu) consisting of LC 10AT liquid pump, Rheodyne injector (2E, 7725; 20µl
To study the accuracy, precision and reproducibility of loop), SPD-10A UV/Vis detector, an ODS Hypersil C-18 the proposed method recovery experiments were carried RP column (25 cm×4.6 mm ID), 25 µl Hamilton injecting out. To an accurately weighed quantity of pre-analyzed syringe and window based single channel software was tablet powder, standard used. Pure drug samples of telmisartan and hydrochlorothiazide (in solution form) were added at hydrochlorothiazide were procured from Aristo four different levels (about 10, 15, 20 and 25% of labeled Pharmaceuticals Ltd., Raisen. The tablet formulations claim). The amount of drug recovered by the proposed Telma-H (Glenmark) and Telpress-H (Nicolas Piramal) was found out. The results of recovery studies are with a labeled claim of 12.5 mg telmisartan and 40 mg shown in Table 2 . Specificity studies were carried out by hydrochlorothiazide were obtained from local drug stores.
deliberately degrading the tablet sample. The stress The solvents acetonitrile and methanol used in the conditions applied were acidic (0.1 M HCl), alkaline (0.1 investigation were of HPLC grade (Merck). Potassium M NaOH) and oxidizing condition (3% H dihydrogen phosphate (0.05 M) was prepared by 24 h. Also heat (60 o ) and UV-exposure for 24 h was dissolving 6.8045 g in 1000 ml of double distilled water and studied. After exposing the samples to above mentioned the pH was adjusted to 3.0 by using orthophosphoric stress conditions for 24 h, the samples were diluted, acid. Buffer (400 ml) and acetonitrile (600 ml) were mixed and filtered through 45 µ filter paper and sonicated. PO (60:40 v/v) as 2 4 of telmisartan and telmisartan and O ) at 50 o for 2 2 Accurately weighed quantity of telmisartan (25.6 mg) and hydrochlorothiazide (8 mg) was transferred to a standard 50 ml volumetric flask, dissolved and diluted to the mark with methanol. The so prepared stock solution was further diluted with mobile phase to get a final concentration range of 4.10-20.48 µg/ml of telmisartan and 1.28-6.4 µg/ml of hydrochlorothiazide. Plotting a graph of peak area vs. concentration allowed the checking of linearity of detector response. can be concluded that the proposed method is accurate, precise, reproducible and specific and can be used for filtered and analyzed in similar manner as described routine analysis of these drugs in combination tablets. under assay of marketed formulation. The results obtained under different stress conditions are as follows:
